Navigation Links
Labopharm settles $1 million draw down under standby equity distribution agreement
Date:1/8/2010

LAVAL, QC, Jan. 8 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has settled the previously announced draw down of $1 million under its standby equity distribution (SEDA) with YA Global Master SPV Ltd. (YA). Under the draw down, Labopharm issued 482,165 of its common shares to YA at a price of $2.07 per common share, net of the applicable discount. (All currency figures are in Canadian dollars.)

In accordance with the terms of the SEDA, the common shares were issued at a discount of 5% to the volume weighted average price (VWAP) on the Toronto Stock Exchange over the ten consecutive trading days following Labopharm's notice of its intention to draw down on the SEDA on December 20, 2009.

Following the completion of the issuance of shares to YA, Labopharm has 57,938,529 shares outstanding.

In connection with the draw down, Labopharm has filed a prospectus supplement to its short-form base shelf prospectus and registration statement to qualify the shares issued to YA. Copies of the final short-form base shelf prospectus, registration statement and prospectus supplement have been filed with SEDAR (www.sedar.com) and EDGAR (www.sec.gov) or may be obtained upon request to the Labopharm contact information below.

Securities Laws Matters

Securities legislation in certain of the provinces of Canada provides purchasers with the right to withdraw f
'/>"/>

SOURCE Labopharm Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe
2. Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
3. Labopharm Reports Results for Third Quarter Fiscal 2009
4. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
5. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
6. Labopharm submits response to FDA for novel antidepressant
7. Labopharm Reports Results for Second Quarter Fiscal 2009
8. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
9. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
10. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
11. Labopharm amends debt facility agreement with Hercules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Muscular Dystrophy ... Biomedical Engineering at Duke University, recently announced a ... and young men with Duchenne muscular dystrophy (DMD). ... Communications, and Gersbach will discuss their implications at ... 11-14 in Washington, D.C. , Background: Gersbach ...
(Date:2/27/2015)... According to the report, the annual revenue ... in 2013 rose by 31.9%. However, in the first ... generated by the industry was recorded at RMB3.623 billion ... industry in 2013. , View Full Report at ... oral industry as a branch of medical industry that ...
(Date:2/27/2015)... Lake City, UT (PRWEB) February 27, 2015 ... Best and Worst Commuter Cities in Florida " ... traffic data from the 2013 U.S. Census Bureau ... 10,000 at the time of the survey. , ... city level, including methods of commuting and a ...
(Date:2/27/2015)... On time and under budget, the doors ... Inside and out, the nearly 900,000-square-foot facility makes good ... the tornado-ravaged St. John’s Regional Medical Center with a ... just 46 months after the tornado hit Joplin, which ... to plan, design and construct a similarly sized hospital,” ...
(Date:2/27/2015)... Fairfax, VA (PRWEB) February 27, 2015 ... currently accepting applications for its next class of Fellows ... the field of radiology business management. , Since ... the significant contributions made by RBMA members to the ... is a prestigious recognition because each Fellow candidate must ...
Breaking Medicine News(10 mins):Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2
... with rheumatoid arthritis who undergo total knee replacement ... according to a new study by researchers at ... City. These reduced expectations, which may be unnecessary, ... postsurgical rehabilitation leading to worse outcomes, say doctors. ...
... , SATURDAY, Nov. 5 (HealthDay News) -- Exposure to certain ... for the painful joint disease known as rheumatoid arthritis, new ... one of the six most common air pollutants in the ... to be presented Wednesday at the American College of Rheumatology ...
... HealthDay Reporter , FRIDAY, Nov. 4 (HealthDay News) -- A ... identifying a gene that is critical in determining which life-saving ... by Genomic Health, results in a number of false-negatives for ... in the Journal of Clinical Oncology . ...
... Cholesterol-lowering medications may help millions fight heart ... control, according to a study presented at the American ... Boston, Nov. 3-8. In the preliminary study ... medication or statins, to 20 patients with asthma who ...
... lab cultures and mice, Johns Hopkins scientists have found that ... causes colon inflammation and increases activity of a gene ... is to expose the gut to hydrogen peroxide the ... cause DNA damage, contributing to the formation of colon tumors, ...
... role in kidney failure, and blocking the action of this ... according to researchers. "We believe these arginase inhibitors may ... the progression of, or even prevent the development of, end-stage ... Penn State College of Medicine. In the United States diabetes ...
Cached Medicine News:Health News:Rheumatoid arthritis patients have low expectations after knee replacement surgery 2Health News:Rheumatoid arthritis patients have low expectations after knee replacement surgery 3Health News:Studies Suggest Link Between Smog, Joint Disease 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 2Health News:Common Breast Cancer Gene Test May Be Flawed, Study Says 3Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 2Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 3Health News:ACAAI Annual Meeting abstracts: Improved outcomes for adults with allergies and asthma 4Health News:Common bacteria cause some colon tumors by altering peroxide-producing gene 2Health News:Research aims to prevent diabetic kidney failure 2
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015 Legislation ... includes a pharmacy provision to help prevent inappropriate prescriptions ... The Protecting the Integrity of Medicare Act (PIMA) ... Subcommittee Chairman Kevin Brady (R-TX) and Ranking ... the prescription drug abuse epidemic and implement the right ...
(Date:2/26/2015)... , Feb. 26, 2015 Research and Markets ... the "Radiation Therapy Equipment - Global Strategic Business ... This report analyzes the worldwide markets for Radiation Therapy ... Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. ... Canada , Japan ...
(Date:2/26/2015)... 2015  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of virus infections, today announced that Jonathan ... President of Finance, a newly created role.  Mr. ... activities, including financial planning and reporting, accounting and ... Jensen , President and CEO. ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
Scorpio CR Knee is designed to address normal knee kinematics, range of motion (ROM) and polyethylene wear....
... The TC-PLUS Solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
Medicine Products: